Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Over the long term, broad indices tend to outperform many active strategies due to lower costs and market-wide diversification.
27,915 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
AI is driving a surge in data centers, but that surge may bring debt challenges. This guide breaks down how to read t...
A fierce bidding war over Two Harbors tested UWM's strategy. This article explains why UWM walked away from harbors c...
As earnings season arrives, praxis medicines 2025 earnings offer a compelling snapshot of where the company stands. T...
An insider at Rackspace Technology recently disclosed a significant stock sale. This article explains what that means...
A fresh AMD collaboration sparked a sharp move in Rackspace shares. This article breaks down what happened, why it ma...
When space stocks surge, investors want to know why. This article breaks down the drivers behind Planet Labs stock we...
From chart-topping beats to smart money moves, this article dives into personal finance lessons inspired by Keith, th...
Lucky To Live Here Realty is joining SERHANT.'s Long Island push, bringing a $1B+ track record to the brokerage. The ...
Two popular short-term bond ETFs target very different risk profiles. This guide breaks down IGSB and VGSH, showing h...
Looking for steady, dependable income from your investments? This guide shows how to locate an industrial stock with ...
With just $60, you can start a thoughtful growth investment. This guide shows how to identify the smartest growth sto...